Back to article: Targeting the TGFβ pathway in uterine carcinosarcoma
FIGURE 2: TGFβ1 in UCS cell proliferation and cisplatin sensitivity.(A) CS-99 and (B) UMMT-ARK1 cells were grown in Matrigel and treated as represented, post 72h treatment cell viability was evaluated using CellTiter-Glo® Luminescent Cell Viability Assay (Promega) and % cell viability compared to Vehicle (V) treated control is plotted. Data are mean ± SD of three independent experiments performed in triplicate. *, P< 0.05.